These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25341748)
1. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis. van Broekhoven DL; Verhoef C; Grünhagen DJ; van Gorp JM; den Bakker MA; Hinrichs JW; de Voijs CM; van Dalen T Ann Surg Oncol; 2015 May; 22(5):1464-70. PubMed ID: 25341748 [TBL] [Abstract][Full Text] [Related]
2. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621 [TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. Carrillo-García J; Hindi N; Conceicao M; Sala MÁ; Ugalde A; López-Pousa A; Bagué S; Sevilla I; Vicioso L; Ramos R; Martínez-Trufero J; Gómez Mateo MC; Cruz J; Hernández-León CN; Redondo A; Mendiola M; García JM; Hernández JE; Álvarez R; Agra C; de Juan-Ferré A; Valverde C; Cano JM; Sande LM; Pérez-Fidalgo JA; Lavernia J; Marcilla D; Gutiérrez A; Moura DS; Martín-Broto J Eur J Cancer; 2024 Sep; 209():114270. PubMed ID: 39142211 [TBL] [Abstract][Full Text] [Related]
4. β-Catenin mutation status and outcomes in sporadic desmoid tumors. Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186 [TBL] [Abstract][Full Text] [Related]
5. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571 [TBL] [Abstract][Full Text] [Related]
6. The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data. Timbergen MJM; Colombo C; Renckens M; Kim HS; Rosmalen JV; Salas S; Mullen JT; Colombo P; Nishida Y; Wiemer EAC; Verhoef C; Sleijfer S; Gronchi A; Grünhagen DJ Ann Surg; 2021 Jun; 273(6):1094-1101. PubMed ID: 31804402 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Guo L; Wang X; Xu B; Lang R; Hu B Future Oncol; 2021 Feb; 17(4):435-442. PubMed ID: 33397129 [No Abstract] [Full Text] [Related]
8. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor. Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222 [TBL] [Abstract][Full Text] [Related]
9. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan. Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220 [TBL] [Abstract][Full Text] [Related]
10. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations. Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042 [TBL] [Abstract][Full Text] [Related]
11. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443 [TBL] [Abstract][Full Text] [Related]
12. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study. Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118 [TBL] [Abstract][Full Text] [Related]
13. Analysis of β-catenin expression and exon 3 mutations in pediatric sporadic aggressive fibromatosis. Bo N; Wang D; Wu B; Chen L; Ruixue Ma Pediatr Dev Pathol; 2012; 15(3):173-8. PubMed ID: 21323417 [TBL] [Abstract][Full Text] [Related]
14. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case. Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714 [TBL] [Abstract][Full Text] [Related]
15. AKT1 and BRAF mutations in pediatric aggressive fibromatosis. Meazza C; Belfiore A; Busico A; Settanni G; Paielli N; Cesana L; Ferrari A; Chiaravalli S; Massimino M; Gronchi A; Colombo C; Pilotti S; Perrone F Cancer Med; 2016 Jun; 5(6):1204-13. PubMed ID: 27062580 [TBL] [Abstract][Full Text] [Related]
16. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis. Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010 [TBL] [Abstract][Full Text] [Related]
17. Lack of Prognostic Value of CTNNB1 Mutation Profile in Desmoid-Type Fibromatosis. Penel N; Bonvalot S; Bimbai AM; Meurgey A; Le Loarer F; Salas S; Piperno-Neumann S; Chevreau C; Boudou-Rouquette P; Dubray-Longeras P; Kurtz JE; Guillemet C; Bompas E; Italiano A; Le Cesne A; Orbach D; Thery J; Le Deley MC; Blay JY; Mir O Clin Cancer Res; 2022 Sep; 28(18):4105-4111. PubMed ID: 35294527 [TBL] [Abstract][Full Text] [Related]
18. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01). Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905 [TBL] [Abstract][Full Text] [Related]
19. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases. Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073 [TBL] [Abstract][Full Text] [Related]
20. β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression. Colombo C; Belfiore A; Paielli N; De Cecco L; Canevari S; Laurini E; Fermeglia M; Pricl S; Verderio P; Bottelli S; Fiore M; Stacchiotti S; Palassini E; Gronchi A; Pilotti S; Perrone F Mol Oncol; 2017 Nov; 11(11):1495-1507. PubMed ID: 28627792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]